Advertisement
For patients with hypertension and obstructive sleep apnea (OSA)

Losartan Reduces Aldosterone in Patients With HTN, Without OSA

0
No significant reductions in response to losartan for those with hypertension and obstructive sleep apnea
In insulin-naive patients with type 2 diabetes

Liraglutide, Sitagliptin Have No Effect on Renal Hemodynamics

0
No change in effective renal plasma flow, other intrarenal hemodynamic measures
Pregabalin significantly improves neuropathic pain

Pregabalin Significantly Improves Neuropathic Pain

0
Pregabalin-linked improvement in pain seen regardless of time since pain onset
A one-week high glycemic index diet increases hepatic fat and glycogen stores in healthy adults compared with a low glycemic index diet

High Glycemic Index Diet Raises Hepatic Fat, Glycogen Stores

0
One-week high GI diet increases hepatic fat and glycogen stores compared with low GI diet
Glycemic index values of the same foods can vary widely and may be an unreliable indicator of blood glucose response

Glycemic Index Poor Indicator of Blood Glucose Response

0
Wide variability seen after eating same food at different times
Early

Intensive T2DM Tx Extends Complication-Free Survival

0
Risk for CV events and microvascular (with exception of peripheral neuropathy) complications down
Fibroblast growth factor 21 genotypes may interact with dietary macronutrient intake to affect central adiposity and body fat composition

FGF21, Dietary Intake Interaction Impacts Adiposity

0
FGF21 genotype interacts with dietary carbohydrate/fat intake to affect adiposity, body fat
Higher levels of free thyroxine may indicate a greater risk of sudden cardiac death

Free Thyroxine Hormone Levels Linked to Sudden Cardiac Death

0
Even patients with levels at the high end of the normal range more likely to experience SCD
For patients with asthma

Review Finds Vitamin D Beneficial for Patients With Asthma

0
Reduction in rate of exacerbations requiring systemic corticosteroids or requiring ER/hospital visit
Patients with type 1 diabetes have more diabetes-associated autoantibodies (DAAs) and non-DAAs than patients with type 2 diabetes

More Diabetes-Associated, Non-Associated Autoantibodies in T1D

0
Systemic immune mediators negatively correlated with diabetes-associated autoantibody titers